IS2143B - Píperasínómetýlbensamíð sem delta-ópíóíðviðtakagerandefni - Google Patents

Píperasínómetýlbensamíð sem delta-ópíóíðviðtakagerandefni

Info

Publication number: IS2143B
Authority: IS; Iceland
Prior art keywords: piperazinomethylbenzamide; delta; receptor agonist; opioid receptor; compounds
Prior art date: 1999-12-20

Application number

IS6426A

Other languages

English (en)

Other versions

IS6426A (is

Inventor

Brown William

Walpole Christopher

Plobeck Niklas

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-20

Filing date

2002-06-18

Publication date

2006-09-15

2002-06-18 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-06-18 Publication of IS6426A publication Critical patent/IS6426A/is

2006-09-15 Publication of IS2143B publication Critical patent/IS2143B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Virology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
Valve-Gear Or Valve Arrangements (AREA)
Liquid Crystal (AREA)
Furan Compounds (AREA)

IS6426A 1999-12-20 2002-06-18 Píperasínómetýlbensamíð sem delta-ópíóíðviðtakagerandefni IS2143B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9904674A SE9904674D0 (sv)	1999-12-20	1999-12-20	Novel compounds
PCT/SE2000/002562 WO2001046174A1 (en)	1999-12-20	2000-12-15	Novel compounds

Publications (2)

Publication Number	Publication Date
IS6426A IS6426A (is)	2002-06-18
IS2143B true IS2143B (is)	2006-09-15

Family

ID=20418210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6426A IS2143B (is)	1999-12-20	2002-06-18	Píperasínómetýlbensamíð sem delta-ópíóíðviðtakagerandefni

Country Status (31)

Country	Link
US (2)	US6680318B2 (is)
EP (1)	EP1242410B1 (is)
JP (1)	JP2003522741A (is)
KR (2)	KR20070090050A (is)
CN (1)	CN1608064A (is)
AT (1)	ATE275143T1 (is)
AU (1)	AU780799B2 (is)
BG (1)	BG65457B1 (is)
BR (1)	BR0016591A (is)
CA (1)	CA2395300A1 (is)
CZ (1)	CZ20022124A3 (is)
DE (1)	DE60013486T2 (is)
DK (1)	DK1242410T3 (is)
EE (1)	EE200200337A (is)
ES (1)	ES2225289T3 (is)
HK (1)	HK1048308B (is)
HU (1)	HUP0300020A3 (is)
IL (2)	IL150125A0 (is)
IS (1)	IS2143B (is)
MX (1)	MXPA02006063A (is)
NO (1)	NO322432B1 (is)
NZ (1)	NZ519986A (is)
PL (1)	PL356780A1 (is)
PT (1)	PT1242410E (is)
RU (1)	RU2258703C2 (is)
SE (1)	SE9904674D0 (is)
SI (1)	SI1242410T1 (is)
SK (1)	SK8832002A3 (is)
UA (1)	UA71650C2 (is)
WO (1)	WO2001046174A1 (is)
ZA (1)	ZA200204255B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040067950A1 (en) *	1998-07-27	2004-04-08	Schering-Plough Corporation	High affinity ligands for nociceptin receptor ORL-1
SE9904674D0 (sv) *	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
EP1395567B1 (en) *	2001-05-18	2009-01-14	AstraZeneca AB	4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
US7030124B2 (en) *	2001-10-29	2006-04-18	Ardent Pharmaceuticals, Inc.	Method of treating depression with delta receptor agonist compounds
SE0203303D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203302D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0301441D0 (sv) *	2003-05-16	2003-05-16	Astrazeneca Ab	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
BRPI0417156A (pt) *	2003-12-12	2007-03-06	Lilly Co Eli	composto, composição farmacêutica, e, métodos para bloquear receptor mu, capa, delta ou combinação (heterodìmero) dos mesmos em mamìferos, para tratar e/ou prevenir doenças relacionadas com obesidade e obesidade, para suprimir apetite em um paciente, para efetuar perda de peso em um paciente obeso
SE0400027D0 (sv) *	2004-01-09	2004-01-09	Astrazeneca Ab	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
MX2007001240A (es)	2004-08-02	2007-03-23	Astrazeneca Ab	Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas.
SE0401968D0 (sv) *	2004-08-02	2004-08-02	Astrazeneca Ab	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
CN101128447A (zh) *	2005-02-28	2008-02-20	阿斯利康(瑞典)有限公司	二芳基甲基哌嗪衍生物，其制备及其用途
GB0606876D0 (en) *	2006-04-05	2006-05-17	Glaxo Group Ltd	Compounds
US20090291966A1 (en) *	2008-05-20	2009-11-26	Astrazeneca Ab	Method Of Treating Anxious Major Depressive Disorder

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH585209A5 (is)	1973-06-29	1977-02-28	Cermol Sa
DE2900810A1 (de)	1979-01-11	1980-07-24	Cassella Ag	Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
IT1140978B (it)	1980-05-23	1986-10-10	Selvi & C Spa	1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche
GB8320701D0 (en)	1983-08-01	1983-09-01	Wellcome Found	Chemotherapeutic agent
IT1196150B (it)	1984-06-19	1988-11-10	Poli Ind Chimica Spa	Derivati di 1-(bis-(4-fluorofenil)metil)-4-(3-fenil-2-propenil)-esaidro-1h-1,4-diazepina ad attivita' calcio antagonista,sua preparazione e composizioni che lo contengono
SE8500573D0 (sv)	1985-02-08	1985-02-08	Ferrosan Ab	Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US5028610A (en)	1987-03-18	1991-07-02	Sankyo Company Limited	N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
US4829065A (en)	1987-04-24	1989-05-09	Syntex Pharmaceuticals, Ltd.	Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US4826844A (en)	1987-09-30	1989-05-02	American Home Products Corporation	Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
AU632888B2 (en)	1989-11-22	1993-01-14	Janssen Pharmaceutica N.V.	Use of piperazine acetamide derivatives against reperfusion damage
US5574159A (en)	1992-02-03	1996-11-12	Delta Pharmaceuticals, Inc.	Opioid compounds and methods for making therefor
GB9202238D0 (en)	1992-02-03	1992-03-18	Wellcome Found	Compounds
US5807858A (en)	1996-06-05	1998-09-15	Delta Pharmaceutical, Inc.	Compositions and methods for reducing respiratory depression
US5681830A (en)	1992-02-03	1997-10-28	Delta Pharmaceuticals, Inc.	Opioid compounds
FR2696744B1 (fr)	1992-10-12	1994-12-30	Logeais Labor Jacques	Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
DK148292D0 (da) *	1992-12-09	1992-12-09	Lundbeck & Co As H	Forbindelser
IL110512A (en)	1993-07-30	1998-10-30	Delta Pharmaceuticals Inc	History of diarylmethyl piperazine, their preparation and pharmaceutical preparations containing them
JP3352184B2 (ja)	1993-11-12	2002-12-03	株式会社アズウェル	ピペラジン不飽和脂肪酸誘導体
US5693843A (en) *	1995-12-22	1997-12-02	E. I. Du Pont De Nemours And Company	Process for hydrocyanation of diolefins and isomerization of nonconjugated 2 alkyl-3-monoalkenenitriles
SE9504661D0 (sv) *	1995-12-22	1995-12-22	Astra Pharma Inc	New compounds
TW548271B (en)	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv) *	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
EP1049676B1 (en)	1997-12-24	2005-10-12	Ortho-Mcneil Pharmaceutical, Inc.	4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
SE9904674D0 (sv) *	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds

1999
- 1999-12-20 SE SE9904674A patent/SE9904674D0/xx unknown
2000
- 2000-12-15 MX MXPA02006063A patent/MXPA02006063A/es active IP Right Grant
- 2000-12-15 SI SI200030501T patent/SI1242410T1/xx unknown
- 2000-12-15 DE DE60013486T patent/DE60013486T2/de not_active Expired - Fee Related
- 2000-12-15 US US10/149,981 patent/US6680318B2/en not_active Expired - Fee Related
- 2000-12-15 ES ES00987916T patent/ES2225289T3/es not_active Expired - Lifetime
- 2000-12-15 PL PL00356780A patent/PL356780A1/xx not_active IP Right Cessation
- 2000-12-15 CN CNA008190461A patent/CN1608064A/zh active Pending
- 2000-12-15 AU AU24184/01A patent/AU780799B2/en not_active Ceased
- 2000-12-15 SK SK883-2002A patent/SK8832002A3/sk unknown
- 2000-12-15 KR KR1020077019022A patent/KR20070090050A/ko not_active Ceased
- 2000-12-15 UA UA2002064617A patent/UA71650C2/uk unknown
- 2000-12-15 HU HU0300020A patent/HUP0300020A3/hu unknown
- 2000-12-15 AT AT00987916T patent/ATE275143T1/de not_active IP Right Cessation
- 2000-12-15 KR KR1020027007836A patent/KR100769814B1/ko not_active Expired - Fee Related
- 2000-12-15 WO PCT/SE2000/002562 patent/WO2001046174A1/en not_active Ceased
- 2000-12-15 BR BR0016591-3A patent/BR0016591A/pt not_active Application Discontinuation
- 2000-12-15 EE EEP200200337A patent/EE200200337A/xx unknown
- 2000-12-15 EP EP00987916A patent/EP1242410B1/en not_active Expired - Lifetime
- 2000-12-15 JP JP2001547084A patent/JP2003522741A/ja not_active Abandoned
- 2000-12-15 CZ CZ20022124A patent/CZ20022124A3/cs unknown
- 2000-12-15 DK DK00987916T patent/DK1242410T3/da active
- 2000-12-15 PT PT00987916T patent/PT1242410E/pt unknown
- 2000-12-15 HK HK03100216.5A patent/HK1048308B/en not_active IP Right Cessation
- 2000-12-15 IL IL15012500A patent/IL150125A0/xx active IP Right Grant
- 2000-12-15 RU RU2002114343/04A patent/RU2258703C2/ru not_active IP Right Cessation
- 2000-12-15 NZ NZ519986A patent/NZ519986A/en unknown
- 2000-12-15 CA CA002395300A patent/CA2395300A1/en not_active Abandoned
2002
- 2002-05-28 ZA ZA200204255A patent/ZA200204255B/en unknown
- 2002-06-10 BG BG106805A patent/BG65457B1/bg unknown
- 2002-06-10 IL IL150125A patent/IL150125A/en not_active IP Right Cessation
- 2002-06-18 NO NO20022920A patent/NO322432B1/no unknown
- 2002-06-18 IS IS6426A patent/IS2143B/is unknown
2003
- 2003-11-17 US US10/714,448 patent/US20040138225A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NZ519986A (en)	2004-06-25
EP1242410A1 (en)	2002-09-25
HK1048308B (en)	2005-04-08
AU780799B2 (en)	2005-04-21
IL150125A (en)	2006-08-20
KR100769814B1 (ko)	2007-10-23
ZA200204255B (en)	2003-08-28
DE60013486D1 (de)	2004-10-07
EP1242410B1 (en)	2004-09-01
NO20022920D0 (no)	2002-06-18
KR20070090050A (ko)	2007-09-04
SI1242410T1 (en)	2004-12-31
PT1242410E (pt)	2004-12-31
JP2003522741A (ja)	2003-07-29
DK1242410T3 (da)	2004-11-29
UA71650C2 (uk)	2004-12-15
US20040138225A1 (en)	2004-07-15
DE60013486T2 (de)	2005-11-17
CZ20022124A3 (cs)	2002-11-13
CA2395300A1 (en)	2001-06-28
ATE275143T1 (de)	2004-09-15
MXPA02006063A (es)	2003-02-06
NO20022920L (no)	2002-07-22
CN1608064A (zh)	2005-04-20
US20030105110A1 (en)	2003-06-05
HK1048308A1 (en)	2003-03-28
SE9904674D0 (sv)	1999-12-20
WO2001046174A1 (en)	2001-06-28
SK8832002A3 (en)	2003-03-04
HUP0300020A2 (en)	2003-05-28
BG106805A (en)	2003-03-31
KR20020062350A (ko)	2002-07-25
NO322432B1 (no)	2006-10-02
RU2002114343A (ru)	2004-01-10
BG65457B1 (bg)	2008-08-29
IS6426A (is)	2002-06-18
ES2225289T3 (es)	2005-03-16
BR0016591A (pt)	2002-09-10
EE200200337A (et)	2003-10-15
RU2258703C2 (ru)	2005-08-20
US6680318B2 (en)	2004-01-20
PL356780A1 (en)	2004-07-12
IL150125A0 (en)	2002-12-01
AU2418401A (en)	2001-07-03
HUP0300020A3 (en)	2005-02-28

Publication	Publication Date	Title
IS6426A (is)	2002-06-18	Píperasínómetýlbensamíð sem delta-ópíóíðviðtakagerandefni
DK0970095T3 (da)	2004-03-08	Hidtil ukendte benzimidazolinhibitorer for fructose-1,6-bisphosphase
EA200300171A1 (ru)	2003-06-26	Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
ATE294803T1 (de)	2005-05-15	Pyrrolobenzodiazepine
EA200300717A1 (ru)	2003-12-25	Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
EA200201119A1 (ru)	2003-06-26	Лиганды меланокортиновых рецепторов
TR200201874T2 (tr)	2002-10-21	Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
EA200100315A1 (ru)	2001-10-22	Простые тетрагидропиридовые эфиры
BR0007864A (pt)	2001-11-06	Composto, e, uso de um composto
SE9900961D0 (sv)	1999-03-16	Novel compounds
IT1285770B1 (it)	1998-06-18	Composti corticoidei
ATE332903T1 (de)	2006-08-15	Kondensierte pyridoindolderivate
ATE326209T1 (de)	2006-06-15	Verminderung des haarwuchses
CO5271666A1 (es)	2003-04-30	Derivados de pirimidina
SE9802208D0 (sv)	1998-06-22	Novel compounds
IL135825A0 (en)	2001-05-20	Use of mirtazapine for treating sleep apneas
SI1546182T1 (sl)	2011-04-29	Sestavki in postopki za diagnozo in zdravljenje tumorja
DE60112960D1 (de)	2005-09-29	Kondensierte pyridoindolderivate
ATE333457T1 (de)	2006-08-15	Zyklische gmp-spezifische phosphodiesteraseinhibitoren
EA200100517A1 (ru)	2001-12-24	Антагонисты 5ht1 для антидепрессантной терапии
ATE259813T1 (de)	2004-03-15	Triazolopyrimidinderivate
DE60121048D1 (de)	2006-08-03	PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
UY26085A1 (es)	2000-10-31	N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
TR200103237T2 (tr)	2002-04-22	İmidazodiazepin türevi
MXPA03003971A (es)	2004-02-12	Derivados de indol como inhibidores de pde5.